Prescriptions for weight loss, diabetes drugs for young people leaped 600% since 2020, study says

Young People in the US Prescribed GLP-1 Agonist Drugs for Weight Loss and Diabetes #

The demand for GLP-1 agonist drugs, such as Wegovy and Ozempic, has surged in the US. Recent research reveals a 594.4% increase in prescriptions for these drugs for people aged 12 to 25 between 2020 and 2023. The study highlights a significant rise in prescriptions for young women and adolescent girls. GLP-1 agonists, approved for type 2 diabetes treatment and weight management, have shown positive effects, including weight loss and improved cardiac and kidney function. These medications might play a crucial role in addressing the increasing prevalence of obesity and diabetes among young people.